Bernard Mahon
Professor
Department of Biology
National University of Maynooth
Ireland
Biography
My scientific work is based on hypothesis-driven, fundamental studies of murine and human immunology. Two major topics are addressed: How do adult mesenchymal stem cells modulate immunity (a question with implications for stem cell therapy, transplantation and tolerance). This work finds application is the design of new cell based therapies; The immunology of early life, particularly at the mucosal surface of the airways. This has led me to examine early life infections with the pathogens B. pertussis, poliovirus and B19V, work which has implications for vaccine design, immunisation protocols and diagnostics. When appropriate, my work has been commercialised or translated to clinical settings. Key recent advances: a) Overcoming the technical problems of adult stem cell therapy; b) a clinical trial of a new whooping cough vaccine with EU partners. I previously served as Faculty dean and VP Research.
Research Interest
Immunology, adult stem cells, cell therapy, vaccines, GvHD, infants, adverse events.My scientific work is based on hypothesis-driven, fundamental studies of murine and human immunology. Two major topics are addressed: How do adult mesenchymal stem cells modulate immunity? (a question with implications for stem cell therapy, transplantation and tolerance). This work finds application is the design of new cell based therapies; The immunology of early life, particularly at the mucosal surface of the airways. This has led me to examine early life infections with the pathogens B. pertussis, poliovirus and B19V, work which has implications for vaccine design, immunisation protocols and diagnostics. When appropriate, my work has been commercialised or translated to clinical settings. Key recent advances: a) Overcoming the technical problems of adult stem cell therapy; b) a clinical trial of a new whooping cough vaccine with EU partners.
Publications
-
Cahill EF;Kennelly H;Carty F;Mahon BP;English K; (2016) 'Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis'. Stem cells translational medicine, 5 (10)
-
McClean S;Healy ME;Collins C;Carberry S;O'Shaughnessy L;Dennehy R;Adams Ã;Kennelly H;Corbett JM;Carty F;Cahill LA;Callaghan M;English K;Mahon BP;Doyle S;Shinoy M; (2016) 'Linocin and OmpW Are Involved in Attachment of the Cystic Fibrosis-Associated Pathogen Burkholderia cepacia Complex to Lung Epithelial Cells and Protect Mice against Infection'. Infection and Immunity, 84 (5)
-
Kennelly, H;Mahon, BP;English, K (2016) 'Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD'. Scientific Reports, 6